391 related articles for article (PubMed ID: 21570871)
1. Contrast medium-induced acute kidney injury: comparison of intravenous and intraarterial administration of iodinated contrast medium.
Karlsberg RP; Dohad SY; Sheng R;
J Vasc Interv Radiol; 2011 Aug; 22(8):1159-65. PubMed ID: 21570871
[TBL] [Abstract][Full Text] [Related]
2. Contrast-induced acute kidney injury (CI-AKI) following intra-arterial administration of iodinated contrast media.
Karlsberg RP; Dohad SY; Sheng R;
J Nephrol; 2010; 23(6):658-66. PubMed ID: 20540038
[TBL] [Abstract][Full Text] [Related]
3. Effects of non-ionic iodinated contrast media on patient heart rate and pressures during intra-cardiac or intra-arterial injection.
Schmid I; Didier D; Pfammatter T; Garachemani A; Fleisch M; Kirchin MA; Meier B
Int J Cardiol; 2007 Jun; 118(3):389-96. PubMed ID: 17376548
[TBL] [Abstract][Full Text] [Related]
4. Nephrotoxicity of iso-osmolar iodixanol compared with nonionic low-osmolar contrast media: meta-analysis of randomized controlled trials.
Heinrich MC; Häberle L; Müller V; Bautz W; Uder M
Radiology; 2009 Jan; 250(1):68-86. PubMed ID: 19092091
[TBL] [Abstract][Full Text] [Related]
5. Risk of contrast-induced nephropathy for patients receiving intravenous vs. intra-arterial iodixanol administration.
Tong GE; Kumar S; Chong KC; Shah N; Wong MJ; Zimmet JM; Wang ZJ; Yee J; Fu Y; Yeh BM
Abdom Radiol (NY); 2016 Jan; 41(1):91-9. PubMed ID: 26830615
[TBL] [Abstract][Full Text] [Related]
6. Cardiac Angiography in Renally Impaired Patients (CARE) study: a randomized double-blind trial of contrast-induced nephropathy in patients with chronic kidney disease.
Solomon RJ; Natarajan MK; Doucet S; Sharma SK; Staniloae CS; Katholi RE; Gelormini JL; Labinaz M; Moreyra AE;
Circulation; 2007 Jun; 115(25):3189-96. PubMed ID: 17562951
[TBL] [Abstract][Full Text] [Related]
7. Nephrotoxicity of iodixanol versus iopamidol in patients undergoing peripheral angiography with or without endovascular therapy.
Xiong HL; Peng M; Jiang XJ; Dong H; Che WQ; Chen Y; Zou YB; Xu B; Yang YJ; Gao RL
Int Urol Nephrol; 2018 Oct; 50(10):1879-1886. PubMed ID: 29948863
[TBL] [Abstract][Full Text] [Related]
8. Subclinical Contrast-Induced Acute Kidney Injury in Patients Undergoing Cerebral Computed Tomography.
Breglia A; Godi I; Virzì GM; Guglielmetti G; Iannucci G; De Cal M; Brocca A; Carta M; Giavarina D; Ankawi G; Passannante A; Yun X; Biolo G; Ronco C
Cardiorenal Med; 2020; 10(2):125-136. PubMed ID: 32036364
[TBL] [Abstract][Full Text] [Related]
9. High incidence of nephropathy in neurosurgical patients after intra-arterial administration of low-osmolar and iso-osmolar contrast media.
Serafin Z; Karolkiewicz M; Gruszka M; Strózecki P; Lasek W; Odrowaz-Sypniewska G; Manitius J; Beuth W
Acta Radiol; 2011 May; 52(4):422-9. PubMed ID: 21498279
[TBL] [Abstract][Full Text] [Related]
10. Comparison of iodixanol and iohexol in patients undergoing intravenous pyelography: a prospective controlled study.
Chuang FR; Chen TC; Wang IK; Chuang CH; Chang HW; Ting-Yu Chiou T; Cheng YF; Lee WC; Chen WC; Yang KD; Lee CH
Ren Fail; 2009; 31(3):181-8. PubMed ID: 19288321
[TBL] [Abstract][Full Text] [Related]
11. Renal toxicity evaluation and comparison between visipaque (iodixanol) and hexabrix (ioxaglate) in patients with renal insufficiency undergoing coronary angiography: the RECOVER study: a randomized controlled trial.
Jo SH; Youn TJ; Koo BK; Park JS; Kang HJ; Cho YS; Chung WY; Joo GW; Chae IH; Choi DJ; Oh BH; Lee MM; Park YB; Kim HS
J Am Coll Cardiol; 2006 Sep; 48(5):924-30. PubMed ID: 16949481
[TBL] [Abstract][Full Text] [Related]
12. Assessment of renal vasoconstriction in vivo after intra-arterial administration of the isosmotic contrast medium iodixanol compared to the low-osmotic contrast medium iopamidol.
Treitl M; Rupprecht H; Wirth S; Korner M; Reiser M; Rieger J
Nephrol Dial Transplant; 2009 May; 24(5):1478-85. PubMed ID: 19033249
[TBL] [Abstract][Full Text] [Related]
13. Contrast-induced nephropathy in patients with chronic kidney disease undergoing computed tomography: a double-blind comparison of iodixanol and iopamidol.
Barrett BJ; Katzberg RW; Thomsen HS; Chen N; Sahani D; Soulez G; Heiken JP; Lepanto L; Ni ZH; Ni ZH; Nelson R
Invest Radiol; 2006 Nov; 41(11):815-21. PubMed ID: 17035872
[TBL] [Abstract][Full Text] [Related]
14. The relative renal safety of iodixanol compared with low-osmolar contrast media: a meta-analysis of randomized controlled trials.
Reed M; Meier P; Tamhane UU; Welch KB; Moscucci M; Gurm HS
JACC Cardiovasc Interv; 2009 Jul; 2(7):645-54. PubMed ID: 19628188
[TBL] [Abstract][Full Text] [Related]
15. The use of gadolinium for arterial interventions.
Sambol EB; Van der Meer JG; Graham A; Goldstein LJ; Karwowski JK; Dayal R; Derubertis B; Kent KC
Ann Vasc Surg; 2011 Apr; 25(3):366-76. PubMed ID: 21288688
[TBL] [Abstract][Full Text] [Related]
16. Incidence of contrast-induced acute kidney injury in a large cohort of all-comers undergoing percutaneous coronary intervention: Comparison of five contrast media.
Azzalini L; Vilca LM; Lombardo F; Poletti E; Laricchia A; Beneduce A; Maccagni D; Demir OM; Slavich M; Giannini F; Carlino M; Margonato A; Cappelletti A; Colombo A
Int J Cardiol; 2018 Dec; 273():69-73. PubMed ID: 30196995
[TBL] [Abstract][Full Text] [Related]
17. Economic evaluation of intravenous iodinated contrast media in Italy.
Iannazzo S; Vandekerckhove S; De Francesco M; Nayak A; Ronco C; Morana G; Valentino M
Int J Technol Assess Health Care; 2014 Jan; 30(1):69-77. PubMed ID: 24485022
[TBL] [Abstract][Full Text] [Related]
18. A meta-analysis of the renal safety of isosmolar iodixanol compared with low-osmolar contrast media.
McCullough PA; Bertrand ME; Brinker JA; Stacul F
J Am Coll Cardiol; 2006 Aug; 48(4):692-9. PubMed ID: 16904536
[TBL] [Abstract][Full Text] [Related]
19. A prospective, double-blind, randomized, controlled trial on the efficacy and cardiorenal safety of iodixanol vs. iopromide in patients with chronic kidney disease undergoing coronary angiography with or without percutaneous coronary intervention.
Nie B; Cheng WJ; Li YF; Cao Z; Yang Q; Zhao YX; Guo YH; Zhou YJ
Catheter Cardiovasc Interv; 2008 Dec; 72(7):958-65. PubMed ID: 19021282
[TBL] [Abstract][Full Text] [Related]
20. Iodixanol versus low-osmolar contrast media for prevention of contrast induced nephropathy: meta-analysis of randomized, controlled trials.
From AM; Al Badarin FJ; McDonald FS; Bartholmai BJ; Cha SS; Rihal CS
Circ Cardiovasc Interv; 2010 Aug; 3(4):351-8. PubMed ID: 20647563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
